These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

765 related articles for article (PubMed ID: 20640864)

  • 1. Physiology and pathophysiology of matrix metalloproteases.
    Klein T; Bischoff R
    Amino Acids; 2011 Jul; 41(2):271-90. PubMed ID: 20640864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases (MMPs) in health and disease: an overview.
    Malemud CJ
    Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalytic activities and substrate specificity of the human membrane type 4 matrix metalloproteinase catalytic domain.
    Wang Y; Johnson AR; Ye QZ; Dyer RD
    J Biol Chem; 1999 Nov; 274(46):33043-9. PubMed ID: 10551873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and Biological Attributes of Matrix Metalloproteinases.
    Cui N; Hu M; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 147():1-73. PubMed ID: 28413025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs.
    Jabłońska-Trypuć A; Matejczyk M; Rosochacki S
    J Enzyme Inhib Med Chem; 2016; 31(sup1):177-183. PubMed ID: 27028474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A synergy between the catalytic and structural Zn(II) ions and the enzyme and substrate dynamics underlies the structure-function relationships of matrix metalloproteinase collagenolysis.
    Varghese A; Chaturvedi SS; Fields GB; Karabencheva-Christova TG
    J Biol Inorg Chem; 2021 Aug; 26(5):583-597. PubMed ID: 34228191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
    Levin M; Udi Y; Solomonov I; Sagi I
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalytic activities of membrane-type 6 matrix metalloproteinase (MMP25).
    English WR; Velasco G; Stracke JO; Knäuper V; Murphy G
    FEBS Lett; 2001 Feb; 491(1-2):137-42. PubMed ID: 11226436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis].
    Fink K; Boratyński J
    Postepy Hig Med Dosw (Online); 2012 Sep; 66():609-28. PubMed ID: 23001203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloprotease inhibitors: design from structure.
    Borkakoti N
    Biochem Soc Trans; 2004 Feb; 32(Pt 1):17-20. PubMed ID: 14748704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MMPs and ADAMTSs: functional studies.
    Flannery CR
    Front Biosci; 2006 Jan; 11():544-69. PubMed ID: 16146752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.
    Wang X; Khalil RA
    Adv Pharmacol; 2018; 81():241-330. PubMed ID: 29310800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining the Substrate Specificity of Matrix Metalloproteases using Fluorogenic Peptide Substrates.
    Stawikowski MJ; Knapinska AM; Fields GB
    Methods Mol Biol; 2017; 1579():137-183. PubMed ID: 28299736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases: fold and function of their catalytic domains.
    Tallant C; Marrero A; Gomis-Rüth FX
    Biochim Biophys Acta; 2010 Jan; 1803(1):20-8. PubMed ID: 19374923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites.
    Overall CM
    Mol Biotechnol; 2002 Sep; 22(1):51-86. PubMed ID: 12353914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosylation of matrix metalloproteases and tissue inhibitors: present state, challenges and opportunities.
    Boon L; Ugarte-Berzal E; Vandooren J; Opdenakker G
    Biochem J; 2016 Jun; 473(11):1471-82. PubMed ID: 27234584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of matrix metalloproteinases: an overview.
    Chakraborti S; Mandal M; Das S; Mandal A; Chakraborti T
    Mol Cell Biochem; 2003 Nov; 253(1-2):269-85. PubMed ID: 14619979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity.
    Uría JA; López-Otín C
    Cancer Res; 2000 Sep; 60(17):4745-51. PubMed ID: 10987280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP).
    Stracke JO; Fosang AJ; Last K; Mercuri FA; Pendás AM; Llano E; Perris R; Di Cesare PE; Murphy G; Knäuper V
    FEBS Lett; 2000 Jul; 478(1-2):52-6. PubMed ID: 10922468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the hemopexin domain of matrix metalloproteinases in cell migration.
    Dufour A; Sampson NS; Zucker S; Cao J
    J Cell Physiol; 2008 Dec; 217(3):643-51. PubMed ID: 18636552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.